Breaking News Instant updates and real-time market news.

COUP

Coupa Software

$202.72 /

+1.74 (+0.87%)

09:05
11/30/21
11/30
09:05
11/30/21
09:05

Coupa Software price target lowered to $280 from $310 at BofA

BofA analyst Brad Sills lowered the firm's price target on Coupa Software to $280 from $310 and keeps a Buy rating on the shares. Partner feedback suggests a gradual uptick in deal activity as pandemic headwinds subside, Sills tells investors in a research note. However, the analyst sees a "less compelling" setup heading into Coupa's fiscal Q3 results. The company remains his top pick for 2022 with billings reacceleration expected in Q4 and fiscal 2023.

  • 06

    Dec

OTHER BREAKING NEWS FROM THE FLY

Conference/Events
Snap One management to meet virtually with Morgan Stanley » 07:34
01/27/22
01/27
07:34
01/27/22
07:34
SNPO

Snap One

$17.84 /

-0.195 (-1.08%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNPO Snap One
$17.84 /

-0.195 (-1.08%)

SNPO Snap One
$17.84 /

-0.195 (-1.08%)

12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
09/30/21 Imperial Capital
Snap One initiated with an Outperform at Imperial Capital
08/23/21 UBS
Snap One initiated with a Buy at UBS
SNPO Snap One
$17.84 /

-0.195 (-1.08%)

  • 28
    Jul
SNPO Snap One
$17.84 /

-0.195 (-1.08%)

SNPO Snap One
$17.84 /

-0.195 (-1.08%)

Hot Stocks
Vivos Therapeutics files for U.S. patent related to clinical methods, protocols » 07:34
01/27/22
01/27
07:34
01/27/22
07:34
VVOS

Vivos Therapeutics

$2.51 /

-0.3 (-10.68%)

Vivos Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VVOS Vivos Therapeutics
$2.51 /

-0.3 (-10.68%)

VVOS Vivos Therapeutics
$2.51 /

-0.3 (-10.68%)

Earnings
Valley National reports Q4 adjusted EPS 28c, consensus 29c » 07:34
01/27/22
01/27
07:34
01/27/22
07:34
VLY

Valley National

$14.50 /

-0.005 (-0.03%)

Valley's regulatory…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLY Valley National
$14.50 /

-0.005 (-0.03%)

VLY Valley National
$14.50 /

-0.005 (-0.03%)

09/24/21 Citi
Valley National upgraded to Neutral from Sell at Citi
09/17/21 Hovde Group
Valley National upgraded to Outperform from Market Perform at Hovde Group
04/14/21 Citi
Valley National price target raised to $12 from $9 at Citi
02/09/21 Keefe Bruyette
Valley National transferred with Outperform at Keefe Bruyette
VLY Valley National
$14.50 /

-0.005 (-0.03%)

Conference/Events
Real Good Food management to meet virtually with William Blair » 07:33
01/27/22
01/27
07:33
01/27/22
07:33
RGF

Real Good Food

$6.01 /

-0.11 (-1.80%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RGF Real Good Food
$6.01 /

-0.11 (-1.80%)

11/30/21
Fly Intel: Top five analyst initiations
11/30/21 Jefferies
Jefferies starts Real Good Food at Buy, sees 75% upside in 12 months
11/30/21 Truist
Real Good Food initiated with a Buy at Truist
11/30/21 William Blair
William Blair starts Real Good Food at Outperform on 'significant white space'
  • 05
    Nov
RGF Real Good Food
$6.01 /

-0.11 (-1.80%)

Earnings
HCA Healthcare reports Q4 EPS $5.75, consensus $4.53 » 07:33
01/27/22
01/27
07:33
01/27/22
07:33
HCA

HCA Healthcare

$239.87 /

+0.46 (+0.19%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$239.87 /

+0.46 (+0.19%)

HCA HCA Healthcare
$239.87 /

+0.46 (+0.19%)

01/10/22 Citi
HCA Healthcare assumed with Buy from Neutral at Citi
01/05/22 Truist
HCA Healthcare price target raised to $310 from $290 at Truist
12/21/21
Fly Intel: Top five analyst downgrades
12/21/21 JPMorgan
JPMorgan downgrades HCA Healthcare, sees 'modest' growth in 2022
HCA HCA Healthcare
$239.87 /

+0.46 (+0.19%)

HCA HCA Healthcare
$239.87 /

+0.46 (+0.19%)

HCA HCA Healthcare
$239.87 /

+0.46 (+0.19%)

Hot Stocks
Sharecare awarded three-year NCQA Population Health Program Accreditation » 07:33
01/27/22
01/27
07:33
01/27/22
07:33
SHCR

Sharecare

$2.98 /

-0.135 (-4.34%)

Sharecare has received…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHCR Sharecare
$2.98 /

-0.135 (-4.34%)

SHCR Sharecare
$2.98 /

-0.135 (-4.34%)

01/18/22 BTIG
BTIG would expect Sharecare to raise 2022 guidance along with Q4 report
01/04/22 BTIG
Sharecare's announcements today 'significant positives,' says BTIG
11/24/21 BTIG
Sharecare 'offers excelling buying opportunity', says BTIG
11/11/21 Canaccord
Sharecare price target raised to $12 at Canaccord after Q3 beat
SHCR Sharecare
$2.98 /

-0.135 (-4.34%)

SHCR Sharecare
$2.98 /

-0.135 (-4.34%)

Recommendations
Boeing price target raised to $288 from $274 at Morgan Stanley » 07:33
01/27/22
01/27
07:33
01/27/22
07:33
BA

Boeing

$194.20 /

-9.96 (-4.88%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$194.20 /

-9.96 (-4.88%)

BA Boeing
$194.20 /

-9.96 (-4.88%)

06:32 Today Wells Fargo
Boeing price target lowered to $250 from $272 at Wells Fargo
01/20/22 Citi
Boeing price target lowered to $238 from $240 at Citi
01/18/22 Cowen
Boeing price target raised to $265 from $250 at Cowen
01/12/22 Morgan Stanley
News of 737 MAX flight in China a positive for Boeing, says Morgan Stanley
BA Boeing
$194.20 /

-9.96 (-4.88%)

BA Boeing
$194.20 /

-9.96 (-4.88%)

BA Boeing
$194.20 /

-9.96 (-4.88%)

BA Boeing
$194.20 /

-9.96 (-4.88%)

Recommendations
ironSource added to Best Ideas List at Wedbush » 07:33
01/27/22
01/27
07:33
01/27/22
07:33
IS

ironSource

$6.23 /

+0.04 (+0.65%)

Wedbush analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IS ironSource
$6.23 /

+0.04 (+0.65%)

IS ironSource
$6.23 /

+0.04 (+0.65%)

12/13/21 Morgan Stanley
ironSource initiated with an Overweight at Morgan Stanley
12/09/21 DA Davidson
DA Davidson starts ironSource at Buy, sees attractive risk/reward profile
12/09/21 DA Davidson
ironSource initiated with a Buy at DA Davidson
12/07/21 Macquarie
ironSource upgraded to Outperform at Macquarie following 40% selloff
IS ironSource
$6.23 /

+0.04 (+0.65%)

IS ironSource
$6.23 /

+0.04 (+0.65%)

IS ironSource
$6.23 /

+0.04 (+0.65%)

Recommendations
Wolfspeed price target lowered to $145 from $155 at Canaccord » 07:33
01/27/22
01/27
07:33
01/27/22
07:33
WOLF

Wolfspeed

$89.75 /

+0.645 (+0.72%)

Canaccord analyst Jed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WOLF Wolfspeed
$89.75 /

+0.645 (+0.72%)

WOLF Wolfspeed
$89.75 /

+0.645 (+0.72%)

06:16 Today Citi
Wolfspeed price target lowered to $125 from $135 at Citi
04:53 Today Piper Sandler
Wolfspeed benefiting from strong market trends, says Piper Sandler
01/12/22 Wells Fargo
Wells Fargo upgrades Wolfspeed to Overweight with a $130 price target
01/12/22 Wells Fargo
Wolfspeed upgraded to Overweight from Equal Weight at Wells Fargo
WOLF Wolfspeed
$89.75 /

+0.645 (+0.72%)

WOLF Wolfspeed
$89.75 /

+0.645 (+0.72%)

WOLF Wolfspeed
$89.75 /

+0.645 (+0.72%)

Hot Stocks
S&T Bancorp raises quarterly dividend to 29c from 28c per share » 07:33
01/27/22
01/27
07:33
01/27/22
07:33
STBA

S&T Bancorp

$32.26 /

-0.59 (-1.80%)

S&T's Board of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STBA S&T Bancorp
$32.26 /

-0.59 (-1.80%)

STBA S&T Bancorp
$32.26 /

-0.59 (-1.80%)

07/12/21 Keefe Bruyette
S&T Bancorp reinstated with a Market Perform at Keefe Bruyette
STBA S&T Bancorp
$32.26 /

-0.59 (-1.80%)

Conference/Events
Bright Health management to meet virtually with Piper Sandler » 07:32
01/27/22
01/27
07:32
01/27/22
07:32
BHG

Bright Health

$2.69 /

-0.12 (-4.27%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHG Bright Health
$2.69 /

-0.12 (-4.27%)

BHG Bright Health
$2.69 /

-0.12 (-4.27%)

01/10/22 Citi
Bright Health assumed with a Neutral at Citi
01/07/22 Barclays
Bright Health price target lowered to $5.50 from $9 at Barclays
12/17/21 Morgan Stanley
Bright Health downgraded to Underweight at Morgan Stanley
12/16/21 Morgan Stanley
Bright Health downgraded to Underweight from Equal Weight at Morgan Stanley
BHG Bright Health
$2.69 /

-0.12 (-4.27%)

  • 24
    Jun
BHG Bright Health
$2.69 /

-0.12 (-4.27%)

Hot Stocks
BridgeBio doses first patient in Phase 1/2 trial of BBP-631 » 07:32
01/27/22
01/27
07:32
01/27/22
07:32
BBIO

BridgeBio

$9.75 /

-0.495 (-4.83%)

BridgeBio Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$9.75 /

-0.495 (-4.83%)

BBIO BridgeBio
$9.75 /

-0.495 (-4.83%)

01/03/22 Piper Sandler
Alnylam upgraded to Overweight from Neutral at Piper Sandler
12/30/21 BofA
Alnylam remains top pick for 2022 at Bofa amid recent volatility
12/28/21 Stifel
Stifel sees no obvious explanation for BridgeBio ATTRibute-CM study failure
12/28/21 Oppenheimer
Ionis weakness associated with peer ATTR failure 'misplaced,' says Oppenheimer
BBIO BridgeBio
$9.75 /

-0.495 (-4.83%)

  • 12
    Feb
BBIO BridgeBio
$9.75 /

-0.495 (-4.83%)

BBIO BridgeBio
$9.75 /

-0.495 (-4.83%)

Recommendations
Oncolytics price target lowered to $6 from $7 at Canaccord » 07:31
01/27/22
01/27
07:31
01/27/22
07:31
ONCY

Oncolytics

$1.85 /

-0.08 (-4.16%)

Canaccord analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONCY Oncolytics
$1.85 /

-0.08 (-4.16%)

ONCY Oncolytics
$1.85 /

-0.08 (-4.16%)

02/17/21 H.C. Wainwright
Oncolytics initiated with a Buy at H.C. Wainwright
ONCY Oncolytics
$1.85 /

-0.08 (-4.16%)

Earnings
S&T Bancorp reports Q4 EPS 57c, consensus 63c » 07:31
01/27/22
01/27
07:31
01/27/22
07:31
STBA

S&T Bancorp

$32.26 /

-0.59 (-1.80%)

Net interest margin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STBA S&T Bancorp
$32.26 /

-0.59 (-1.80%)

STBA S&T Bancorp
$32.26 /

-0.59 (-1.80%)

07/12/21 Keefe Bruyette
S&T Bancorp reinstated with a Market Perform at Keefe Bruyette
STBA S&T Bancorp
$32.26 /

-0.59 (-1.80%)

Hot Stocks
Afya announces new share repurchase plan » 07:30
01/27/22
01/27
07:30
01/27/22
07:30
AFYA

Afya

$12.76 /

+0.15 (+1.19%)

Afya announced that,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AFYA Afya
$12.76 /

+0.15 (+1.19%)

AFYA Afya
$12.76 /

+0.15 (+1.19%)

07/21/21
Fly Intel: Top five analyst downgrades
07/21/21 Morgan Stanley
Afya downgraded to Equal Weight from Overweight at Morgan Stanley
04/15/21 UBS
UBS upgrades Afya to Buy on 'underappreciated resiliency'
04/15/21 UBS
Afya upgraded to Buy from Neutral at UBS
AFYA Afya
$12.76 /

+0.15 (+1.19%)

Recommendations
ServiceNow price target lowered to $615 from $715 at Canaccord » 07:29
01/27/22
01/27
07:29
01/27/22
07:29
NOW

ServiceNow

$483.57 /

-11.64 (-2.35%)

Canaccord analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

07:25 Today Baird
ServiceNow price target lowered to $600 from $650 at Baird
07:03 Today BMO Capital
ServiceNow price target raised to $635 from $600 at BMO Capital
06:56 Today Credit Suisse
ServiceNow price target lowered to $800 from $850 at Credit Suisse
06:49 Today Mizuho
ServiceNow price target raised to $650 from $615 at Mizuho
NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

Downgrade
Haemonetics downgraded to Hold from Buy at Needham » 07:28
01/27/22
01/27
07:28
01/27/22
07:28
HAE

Haemonetics

$47.34 /

-1.92 (-3.90%)

Needham analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$47.34 /

-1.92 (-3.90%)

HAE Haemonetics
$47.34 /

-1.92 (-3.90%)

06:09 Today Needham
Haemonetics downgraded to Hold from Buy at Needham
12/15/21 Citi
Haemonetics downgraded to Neutral from Buy at Citi
11/10/21 JMP Securities
Haemonetics price target lowered to $80 from $90 at JMP Securities
06/17/21 Citi
Haemonetics initiated with a Buy at Citi
HAE Haemonetics
$47.34 /

-1.92 (-3.90%)

HAE Haemonetics
$47.34 /

-1.92 (-3.90%)

Hot Stocks
Cactus increases quarterly cash dividend to 11c per share » 07:28
01/27/22
01/27
07:28
01/27/22
07:28
WHD

Cactus

$49.37 /

+1.19 (+2.47%)

Cactus announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WHD Cactus
$49.37 /

+1.19 (+2.47%)

WHD Cactus
$49.37 /

+1.19 (+2.47%)

11/11/21 Citi
Cactus price target raised to $50 from $41 at Citi
10/25/21 Barclays
Cactus price target raised to $50 from $42 at Barclays
07/02/21 Stifel
Cactus price target raised to $43 from $38 at Stifel
05/03/21 Barclays
Cactus upgraded to Overweight from Equal Weight at Barclays
WHD Cactus
$49.37 /

+1.19 (+2.47%)

  • 10
    Mar
Earnings
Popular reports Q4 EPS $2.58, consensus $2.23 » 07:27
01/27/22
01/27
07:27
01/27/22
07:27
BPOP

Popular

$88.82 /

-0.75 (-0.84%)

Reports Q4 net interest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPOP Popular
$88.82 /

-0.75 (-0.84%)

BPOP Popular
$88.82 /

-0.75 (-0.84%)

11/09/21
Fly Intel: Top five analyst initiations
11/09/21 Wells Fargo
Wells Fargo starts Popular at Overweight, calls top pick among Puerto Rico banks
11/09/21 Wells Fargo
Popular initiated with an Overweight at Wells Fargo
10/21/21 RBC Capital
Popular price target raised to $91 from $83 at RBC Capital
BPOP Popular
$88.82 /

-0.75 (-0.84%)

Hot Stocks
Kirby provides updated outlook for FY22, sees 'strong momentum building' » 07:26
01/27/22
01/27
07:26
01/27/22
07:26
KEX

Kirby

$62.09 /

-0.36 (-0.58%)

Commenting on the 2022…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KEX Kirby
$62.09 /

-0.36 (-0.58%)

KEX Kirby
$62.09 /

-0.36 (-0.58%)

01/03/22 Stephens
Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
10/12/21 Stifel
Kirby upgraded to Buy from Hold at Stifel
05/07/21 Gabelli
Kirby downgraded to Hold at Gabelli on decelerating earnings growth after 2023
05/07/21 Gabelli
Kirby downgraded to Hold from Buy at Gabelli
KEX Kirby
$62.09 /

-0.36 (-0.58%)

Hot Stocks
4D pharma announces additional data from Part A of MRx-4DP0004 trial » 07:26
01/27/22
01/27
07:26
01/27/22
07:26
LBPS

4D pharma

$3.80 /

+ (+0.00%)

4D pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LBPS 4D pharma
$3.80 /

+ (+0.00%)

LBPS 4D pharma
$3.80 /

+ (+0.00%)

07/09/21 Chardan
4D pharma assumed with a Buy at Chardan
05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
Downgrade
Gatos downgraded to Hold on 'material setback' at Canaccord » 07:26
01/27/22
01/27
07:26
01/27/22
07:26
GATO

Gatos Silver

$3.18 /

-6.995 (-68.75%)

Canaccord analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GATO Gatos Silver
$3.18 /

-6.995 (-68.75%)

GATO Gatos Silver
$3.18 /

-6.995 (-68.75%)

01/26/22 Canaccord
Gatos Silver downgraded to Hold from Buy at Canaccord
01/26/22 CIBC
Gatos Silver downgraded to Neutral from Outperformer at CIBC
01/26/22 RBC Capital
Gatos Silver double-downgraded to Underperform from Outperform at RBC Capital
01/26/22 RBC Capital
Gatos Silver downgraded to Underperform from Outperform at RBC Capital
GATO Gatos Silver
$3.18 /

-6.995 (-68.75%)

  • 15
    Jul
GATO Gatos Silver
$3.18 /

-6.995 (-68.75%)

GATO Gatos Silver
$3.18 /

-6.995 (-68.75%)

Initiation
Planet Labs initiated with a Buy at Needham » 07:26
01/27/22
01/27
07:26
01/27/22
07:26
PL

Planet Labs

$5.51 /

+0.16 (+2.99%)

Needham analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PL Planet Labs
$5.51 /

+0.16 (+2.99%)

PL Planet Labs
$5.51 /

+0.16 (+2.99%)

06:18 Today Needham
Planet Labs initiated with a Buy at Needham
01/12/22 Goldman Sachs
Planet Labs initiated with a Buy at Goldman Sachs
01/07/22 Wedbush
Planet Labs initiated with an Outperform at Wedbush
01/07/22 Piper Sandler
Planet Labs initiated with an Overweight at Piper Sandler
PL Planet Labs
$5.51 /

+0.16 (+2.99%)

PL Planet Labs
$5.51 /

+0.16 (+2.99%)

PL Planet Labs
$5.51 /

+0.16 (+2.99%)

Recommendations
ServiceNow price target lowered to $600 from $650 at Baird » 07:25
01/27/22
01/27
07:25
01/27/22
07:25
NOW

ServiceNow

$483.57 /

-11.64 (-2.35%)

Baird analyst Rob Oliver…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

07:03 Today BMO Capital
ServiceNow price target raised to $635 from $600 at BMO Capital
06:56 Today Credit Suisse
ServiceNow price target lowered to $800 from $850 at Credit Suisse
06:49 Today Mizuho
ServiceNow price target raised to $650 from $615 at Mizuho
06:15 Today Citi
ServiceNow price target raised to $675 from $657 at Citi
NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

NOW ServiceNow
$483.57 /

-11.64 (-2.35%)

Hot Stocks
Li-Cycle expands partnership with Ultium Cells for recyling facility operation » 07:25
01/27/22
01/27
07:25
01/27/22
07:25
LICY

Li-Cycle

$7.04 /

-0.265 (-3.63%)

, GM

General Motors

$52.38 /

+0.51 (+0.98%)

Li-Cycle (LICY) will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LICY Li-Cycle
$7.04 /

-0.265 (-3.63%)

GM General Motors
$52.38 /

+0.51 (+0.98%)

LICY Li-Cycle
$7.04 /

-0.265 (-3.63%)

01/11/22 Piper Sandler
Li-Cycle price target lowered to $15 from $18 at Piper Sandler
12/01/21 BMO Capital
GM shift into cathode production positive for Li-Cycle, says BMO Capital
11/23/21
Fly Intel: Top five analyst initiations
11/23/21 Chardan
Li-Cycle initiated with a Buy at Chardan
GM General Motors
$52.38 /

+0.51 (+0.98%)

01/24/22 BofA
Bofa adds two, removes three from best investment ideas list
01/13/22 Deutsche Bank
Deutsche Bank sees 2022 guidance misses from these auto companies
01/13/22 Deutsche Bank
General Motors price target raised to $71 from $67 at Deutsche Bank
01/05/22 Citi
Citi has 'mixed' views on GM's Silverado electric vehicle
LICY Li-Cycle
$7.04 /

-0.265 (-3.63%)

GM General Motors
$52.38 /

+0.51 (+0.98%)

GM General Motors
$52.38 /

+0.51 (+0.98%)

LICY Li-Cycle
$7.04 /

-0.265 (-3.63%)

GM General Motors
$52.38 /

+0.51 (+0.98%)

LICY Li-Cycle
$7.04 /

-0.265 (-3.63%)

GM General Motors
$52.38 /

+0.51 (+0.98%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.